Magnesium in PDB 5lkc: Protruding Domain of Gii.17 Norovirus KAWASAKI308 in Complex with Hbga Type A (Triglycan)
Protein crystallography data
The structure of Protruding Domain of Gii.17 Norovirus KAWASAKI308 in Complex with Hbga Type A (Triglycan), PDB code: 5lkc
was solved by
B.K.Singh,
V.Morozov,
G.S.Hansman,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
48.72 /
1.81
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
75.870,
86.730,
97.440,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
15.3 /
18.3
|
Magnesium Binding Sites:
The binding sites of Magnesium atom in the Protruding Domain of Gii.17 Norovirus KAWASAKI308 in Complex with Hbga Type A (Triglycan)
(pdb code 5lkc). This binding sites where shown within
5.0 Angstroms radius around Magnesium atom.
In total 2 binding sites of Magnesium where determined in the
Protruding Domain of Gii.17 Norovirus KAWASAKI308 in Complex with Hbga Type A (Triglycan), PDB code: 5lkc:
Jump to Magnesium binding site number:
1;
2;
Magnesium binding site 1 out
of 2 in 5lkc
Go back to
Magnesium Binding Sites List in 5lkc
Magnesium binding site 1 out
of 2 in the Protruding Domain of Gii.17 Norovirus KAWASAKI308 in Complex with Hbga Type A (Triglycan)
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 1 of Protruding Domain of Gii.17 Norovirus KAWASAKI308 in Complex with Hbga Type A (Triglycan) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Mg603
b:14.7
occ:1.00
|
H
|
A:PHE517
|
2.3
|
23.5
|
1.0
|
H
|
A:LEU229
|
2.4
|
19.9
|
1.0
|
HE
|
A:ARG516
|
2.5
|
50.1
|
1.0
|
HB3
|
A:PHE517
|
3.1
|
23.5
|
1.0
|
N
|
A:PHE517
|
3.2
|
19.6
|
1.0
|
HA
|
A:ARG516
|
3.2
|
24.0
|
1.0
|
N
|
A:LEU229
|
3.2
|
16.6
|
1.0
|
HA
|
A:SER228
|
3.3
|
23.1
|
1.0
|
O
|
A:HOH906
|
3.3
|
39.6
|
1.0
|
NE
|
A:ARG516
|
3.3
|
41.8
|
1.0
|
HH21
|
A:ARG516
|
3.3
|
63.9
|
1.0
|
HB2
|
A:LEU229
|
3.4
|
20.5
|
1.0
|
HB2
|
A:SER228
|
3.6
|
26.5
|
1.0
|
HG
|
A:LEU229
|
3.7
|
21.6
|
1.0
|
HB2
|
A:PHE517
|
3.7
|
23.5
|
1.0
|
CB
|
A:PHE517
|
3.7
|
19.6
|
1.0
|
O
|
A:LEU229
|
3.8
|
20.3
|
1.0
|
HB3
|
A:ARG516
|
3.8
|
28.1
|
1.0
|
HD2
|
A:ARG516
|
3.9
|
40.9
|
1.0
|
HD11
|
A:ILE231
|
3.9
|
55.0
|
1.0
|
CA
|
A:ARG516
|
4.0
|
20.0
|
1.0
|
CA
|
A:SER228
|
4.0
|
19.3
|
1.0
|
NH2
|
A:ARG516
|
4.0
|
53.2
|
1.0
|
CB
|
A:LEU229
|
4.0
|
17.1
|
1.0
|
CA
|
A:PHE517
|
4.0
|
19.4
|
1.0
|
C
|
A:ARG516
|
4.1
|
20.5
|
1.0
|
CA
|
A:LEU229
|
4.1
|
16.1
|
1.0
|
C
|
A:SER228
|
4.1
|
18.1
|
1.0
|
CZ
|
A:ARG516
|
4.1
|
50.0
|
1.0
|
CD
|
A:ARG516
|
4.2
|
34.1
|
1.0
|
CB
|
A:SER228
|
4.2
|
22.1
|
1.0
|
HD12
|
A:LEU229
|
4.2
|
22.5
|
1.0
|
CG
|
A:LEU229
|
4.3
|
18.0
|
1.0
|
CB
|
A:ARG516
|
4.4
|
23.4
|
1.0
|
C
|
A:LEU229
|
4.4
|
17.8
|
1.0
|
HD13
|
A:ILE231
|
4.4
|
55.0
|
1.0
|
O
|
A:HOH725
|
4.6
|
42.6
|
1.0
|
CD1
|
A:ILE231
|
4.6
|
45.9
|
1.0
|
O
|
A:PHE517
|
4.6
|
20.5
|
1.0
|
HB3
|
A:SER228
|
4.6
|
26.5
|
1.0
|
HA
|
A:PHE517
|
4.8
|
23.3
|
1.0
|
CD1
|
A:LEU229
|
4.8
|
18.7
|
1.0
|
O
|
A:HOH811
|
4.8
|
41.4
|
1.0
|
HH22
|
A:ARG516
|
4.8
|
63.9
|
1.0
|
C
|
A:PHE517
|
4.9
|
20.2
|
1.0
|
HB3
|
A:LEU229
|
4.9
|
20.5
|
1.0
|
CG
|
A:ARG516
|
4.9
|
28.1
|
1.0
|
HD12
|
A:ILE231
|
4.9
|
55.0
|
1.0
|
HD3
|
A:ARG516
|
4.9
|
40.9
|
1.0
|
HD2
|
A:PHE517
|
5.0
|
31.3
|
1.0
|
HA
|
A:LEU229
|
5.0
|
19.3
|
1.0
|
|
Magnesium binding site 2 out
of 2 in 5lkc
Go back to
Magnesium Binding Sites List in 5lkc
Magnesium binding site 2 out
of 2 in the Protruding Domain of Gii.17 Norovirus KAWASAKI308 in Complex with Hbga Type A (Triglycan)
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 2 of Protruding Domain of Gii.17 Norovirus KAWASAKI308 in Complex with Hbga Type A (Triglycan) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Mg603
b:18.1
occ:1.00
|
H
|
B:LEU229
|
2.3
|
23.4
|
1.0
|
H
|
B:PHE517
|
2.4
|
27.1
|
1.0
|
HE
|
B:ARG516
|
2.4
|
54.8
|
1.0
|
HB3
|
B:PHE517
|
3.1
|
29.7
|
1.0
|
N
|
B:LEU229
|
3.2
|
19.5
|
1.0
|
N
|
B:PHE517
|
3.2
|
22.6
|
1.0
|
HA
|
B:ARG516
|
3.2
|
30.3
|
1.0
|
HA
|
B:SER228
|
3.3
|
24.7
|
1.0
|
NE
|
B:ARG516
|
3.3
|
45.7
|
1.0
|
HH21
|
B:ARG516
|
3.3
|
59.7
|
1.0
|
HB2
|
B:SER228
|
3.4
|
28.8
|
1.0
|
HB2
|
B:LEU229
|
3.4
|
20.9
|
1.0
|
HG
|
B:LEU229
|
3.7
|
22.9
|
1.0
|
CB
|
B:PHE517
|
3.8
|
24.8
|
1.0
|
HB3
|
B:ARG516
|
3.8
|
36.5
|
1.0
|
O
|
B:LEU229
|
3.8
|
21.0
|
1.0
|
HB2
|
B:PHE517
|
3.8
|
29.7
|
1.0
|
HD2
|
B:ARG516
|
3.8
|
49.2
|
1.0
|
HD11
|
B:ILE231
|
3.9
|
50.3
|
1.0
|
CA
|
B:SER228
|
3.9
|
20.6
|
1.0
|
CA
|
B:ARG516
|
4.0
|
25.2
|
1.0
|
NH2
|
B:ARG516
|
4.0
|
49.7
|
1.0
|
CB
|
B:LEU229
|
4.0
|
17.5
|
1.0
|
CA
|
B:LEU229
|
4.0
|
18.0
|
1.0
|
CA
|
B:PHE517
|
4.0
|
23.9
|
1.0
|
C
|
B:SER228
|
4.1
|
18.9
|
1.0
|
C
|
B:ARG516
|
4.1
|
23.9
|
1.0
|
CZ
|
B:ARG516
|
4.1
|
46.9
|
1.0
|
CB
|
B:SER228
|
4.1
|
24.0
|
1.0
|
CD
|
B:ARG516
|
4.1
|
41.0
|
1.0
|
CG
|
B:LEU229
|
4.3
|
19.1
|
1.0
|
CB
|
B:ARG516
|
4.3
|
30.4
|
1.0
|
HD12
|
B:LEU229
|
4.3
|
25.8
|
1.0
|
C
|
B:LEU229
|
4.4
|
18.4
|
1.0
|
HD13
|
B:ILE231
|
4.4
|
50.3
|
1.0
|
HB3
|
B:SER228
|
4.5
|
28.8
|
1.0
|
O
|
B:PHE517
|
4.5
|
26.2
|
1.0
|
CD1
|
B:ILE231
|
4.6
|
41.9
|
1.0
|
O
|
B:HOH712
|
4.6
|
29.4
|
1.0
|
HH22
|
B:ARG516
|
4.8
|
59.7
|
1.0
|
C
|
B:PHE517
|
4.8
|
25.1
|
1.0
|
HA
|
B:PHE517
|
4.8
|
28.6
|
1.0
|
HD12
|
B:ILE231
|
4.9
|
50.3
|
1.0
|
CG
|
B:ARG516
|
4.9
|
35.6
|
1.0
|
CD1
|
B:LEU229
|
4.9
|
21.5
|
1.0
|
HD3
|
B:ARG516
|
4.9
|
49.2
|
1.0
|
HD2
|
B:PHE517
|
4.9
|
33.1
|
1.0
|
HA
|
B:LEU229
|
4.9
|
21.6
|
1.0
|
HB3
|
B:LEU229
|
4.9
|
20.9
|
1.0
|
|
Reference:
A.Koromyslova,
S.Tripathi,
V.Morozov,
H.Schroten,
G.S.Hansman.
Human Norovirus Inhibition By A Human Milk Oligosaccharide. Virology V. 508 81 2017.
ISSN: ISSN 1096-0341
PubMed: 28505592
DOI: 10.1016/J.VIROL.2017.04.032
Page generated: Sun Sep 29 20:14:35 2024
|